| Literature DB >> 36068369 |
Rossana Aboud Matos de Almeida1, Suellen Nogueira Linares Lima1, Maria Vitória Nassif2, Natanael Henrique Ribeiro Mattos2, Thalita Paris de Matos2,3, Rudys Rodolfo de Jesus Tavarez1, Andres Felipe Millan Cardenas1, Matheus Coelho Bandeca1,2, Alessandro D Loguercio4.
Abstract
OBJECTIVE: The aim of this double-blind, randomized clinical trial was to evaluate the 6- and 18-month clinical performances of a new universal adhesive applied in the "no-waiting" (NW) technique to non-carious cervical lesions (NCCLs) using two evaluation criteria.Entities:
Keywords: Application time; Clinical trial; Non-carious cervical lesion; Universal adhesives
Year: 2022 PMID: 36068369 PMCID: PMC9447982 DOI: 10.1007/s00784-022-04703-7
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.606
Fig. 1Participant flow diagram in the different phases of the study design. Abbreviations: Np, number of participants; Nr, number of restorations
Adhesive system, manufacturer, batch number, composition, and application mode
| Material/manufacturer/batch number | pH | Composition* | Application technique** | |
|---|---|---|---|---|
| Etch-and-rinse (ER) | Self-etch (SE) | |||
| Prime&Bond Active (PB)/Dentsply Sirona; Konstanz, Germany/1709000735 | 2.6 | Phosphoric acid modified acrylate resins, PENTA, 10-MDP, multifunctional acrylate, bifunctional acrylate, acid acrylate, isoproponol, water, initiator, stabilizer | 1. Apply Etchant for 15 s 2. Rinse for 10 s 3. Air dry to remove excess of water 4. Apply the adhesive for 20 s with vigorous agitation 5. Gently air thin for 5 s 6. Light-cure for 10 s (1000 mW/cm2) | 1. Apply the adhesive for 20 s with vigorous agitation 2. Gently air thin for 5 s 3. Light-cure for 10 s (1000 mW/cm2) |
| Clearfil Universal Bond Quick (CQ)/Kuraray Noritake, Tokyo, Japan/2L0104 | 2.3 | Bis-GMA, HEMA, 10-MDP, hydrophilic amide monomer, colloidal silica, silane coupling agent, sodium fluoride, camphorquinone, ethanol, water | 7. Apply Etchant for 15 s 8. Rinse for 10 s 9. Air dry to remove excess of water 10 Apply the adhesive with vigorous agitation (no-waiting time) 11. Gently air thin for 5 s 12. Light-cure for 10 s (1000 mW/cm2) | 1. Apply the adhesive with vigorous agitation (no-waiting time) 2. Gently air thin for 5 s 3. Light-cure for 10 s (1000 mW/cm2) |
*PENTA dipentaerythritol pentacrylate phosphate, 10-MDP 10-methacryloyloxydecyl dihydrogen phosphate, HEMA 2-hydroxyethyl methacrylate, Bis-GMA 2,2 bis[4-(2-hydroxy-3-methacrylyloxy-propoxy)-phenyl] propane, 10-MDP 10-methacryloyloxydecyl dihydrogen phosphate
**According to the manufacturer’s instructions
World Dental Federation (FDI) criteria used for clinical evaluation [33]
| Esthetic property | Functional properties | Biological properties | |||
|---|---|---|---|---|---|
| 1. Staining margin | 2. Fractures and retention | 3. Marginal Adaptation | 4. Postoperative (hyper) sensitivity | 5. Recurrence of caries | |
| 1. Clinically very good | 1.1 No marginal staining | 2.1 Restoration retained, no fractures/cracks | 3.1 Harmonious outline, no gaps, no discoloration | 4.1 No hypersensitivity | 5.1 No secondary or primary caries |
| 2. Clinically good (after correction very good) | 1.2 Minor marginal staining, easily removable by polishing | 2.2 Small hairline crack | 3.2.1 Marginal gap (50 μm) 3.2.2 Small marginal fracture removable by polishing | 4.2 Low hypersensitivity for a limited period of time | 5.2 Very small and localized demineralization No operative treatment required |
| 3. Clinically sufficient/satisfactory (minor problems with no adverse effects but not adjustable without damage to the tooth) | 1.3 Moderate marginal staining, not esthetically | 2.3 Two or more or larger hairline cracks and/or chipping (not affecting the marginal integrity) | 3.3.1 Gap < 150 μm not removable 3.3.2. Several small enamel or dentin fractures | 4.3.1 Premature/slightly more intense 4.3.2 Delayed/weak sensitivity; no subjective complaints, no treatment needed | 5.3 Larger areas of demineralization, but only preventive measures necessary (dentine not exposed) |
| 4. Clinically unsatisfactory (repair for prophylactic reasons) | 1.4 Pronounced marginal staining; major intervention necessary for improvement | 2.4 Chipping fractures which damage marginal quality; bulk fractures with or without partial loss (less than half of the restoration) | 3.4.1 Gap > 250 μm or dentine/base exposed 3.4.2. chip fracture damaging margins 3.4.3 Notable enamel or dentine wall fracture | 4.4.1 Premature/very intense 4.4.2 Extremely delayed/weak with subjective complaints 4.4.3 Negative Sensitivity Intervention necessary but not replacement | 5. 4 Caries with cavitation (localized and accessible and can be repaired |
| 5. Clinically poor (replacement necessary) | 1.5 Deep marginal staining not accessible for intervention | 2.5 (Partial or complete) loss of restoration | 3.5 Filling is loose but in situ | 5.5 Deep secondary caries or exposed dentine that is not accessible for repair of restoration | 5.5 Deep secondary caries or exposed dentine that is not accessible for repair of restoration |
| Acceptable or not acceptable ( | Aesthetic criteria | Functional criteria | Biological criteria | ||
Modified United States Public Health Service (USPHS) [34, 35]
| Marginal staining | Retention | Fracture | Marginal adaptation | Postoperative sensitivity | Recurrence of caries | |
|---|---|---|---|---|---|---|
| Alfa | No discoloration along the margin | Retained | None | Restoration is continuous with existing anatomic form | No postoperative sensitivity directly after the restorative process and during the study period | None evidence of caries contiguous with the margin |
| Bravo | Slight and superficial staining (removable, usually localized) | Partially retained | Small chip, but clinically acceptable | Detectable V-shaped defect in enamel only Catches explorer going both ways | – | – |
| Charlie | Deep staining cannot be polished away | Missing | Failure due to Bulk restorative fracture | Detectable V-shaped defect to dentin-enamel junction | Sensitivity present at any time during the study period | Evidence of presence of caries |
Characteristics of the research subjects and the non-carious cervical lesions (NCCLs) per group
| Characteristics of research subjects | Number of participants | |||
| Gender distribution | ||||
| Male | 12 | |||
| Female | 12 | |||
| Age distribution (years) | ||||
| 20–29 | 00 | |||
| 30–39 | 08 | |||
| 39–49 | 08 | |||
| > 49 | 08 | |||
| Characteristics of Class-V lesions | Number of lesions | |||
| PB-ER | PB-SE | CQ-ER | CQ-SE | |
| Shape (degree of angle) | ||||
| < 45 | - | - | - | - |
| 45–90 | 12 | 11 | 13 | 12 |
| 90–135 | 24 | 22 | 21 | 21 |
| > 135 | 8 | 11 | 10 | 11 |
| Cervico-incisal height (mm) | ||||
| < 1.5 | 10 | 9 | 11 | 7 |
| 1.5–2.5 | 22 | 24 | 22 | 28 |
| 2.5–4.0 | 9 | 10 | 9 | 8 |
| > 4.0 | 3 | - | 1 | 1 |
| Degree of sclerotic dentin | ||||
| 1 | 23 | 23 | 21 | 19 |
| 2 | 18 | 18 | 19 | 22 |
| 3 | 3 | 3 | 4 | 3 |
| 4 | - | - | - | - |
| Presence of antagonist | ||||
| Yes | 44 | 44 | 44 | 44 |
| No | - | - | - | - |
| Attrition facet | ||||
| Yes | 18 | 16 | 18 | 15 |
| No | 26 | 28 | 26 | 29 |
| Pre-operative sensitivity (spontaneous) | ||||
| Yes | 1 | 1 | - | 3 |
| No | 43 | 43 | 44 | 41 |
| Pre-operative sensitivity (air dry) | ||||
| Yes | 26 | 28 | 29 | 31 |
| No | 18 | 16 | 15 | 13 |
| Pre-operative sensitivity (touch) | ||||
| Yes | 25 | 28 | 28 | 30 |
| No | 19 | 16 | 16 | 14 |
| Tooth distribution | ||||
| Anterior | ||||
| Incisor | 05 | 05 | 02 | 04 |
| Canines | 06 | 04 | 08 | 07 |
| Posterior | ||||
| Premolar | 24 | 24 | 20 | 24 |
| Molar | 9 | 11 | 14 | 9 |
| Arc distribution | ||||
| Maxillary | 24 | 31 | 29 | 29 |
| Mandibular | 20 | 13 | 15 | 15 |
Number of evaluated restorations for each experimental group* classified according to the Modified US Public Health Service (USPHS) criteria [34, 35]
| USPHS criteria | ** | Baseline | 6 months | 18 months | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PB-ER | PB-SE | CQ-ER | CQ-SE | PB-ER | PB-SE | CQ-ER | CQ-SE | PB-ER | PB-SE | CQ-ER | CQ-SE | ||
| Marginal staining | A | 44 | 44 | 44 | 44 | 44 | 41 | 44 | 42 | 42 | 39 | 44 | 38 |
| B | – | – | – | – | – | – | – | – | – | 01 | – | 02 | |
| C | – | – | – | – | – | – | – | – | – | – | – | – | |
| Fractures and retention | A | 44 | 44 | 44 | 44 | 44 | 41 | 44 | 42 | 42 | 40 | 44 | 40 |
| B | – | – | – | – | – | 1 | – | – | – | – | – | – | |
| C | – | – | – | – | – | 02 | 02 | 02 | 01 | – | 02 | ||
| Marginal adaptation | A | 44 | 44 | 44 | 44 | 44 | 39 | 44 | 40 | 42 | 40 | 44 | 37 |
| B | – | – | – | – | – | 02 | – | 02 | – | – | – | 03 | |
| C | – | – | – | – | – | – | – | – | – | – | – | – | |
| Post-operative (hyper-) sensitivity | A | 44 | 44 | 44 | 44 | 44 | 41 | 44 | 42 | 42 | 40 | 44 | 40 |
| B | – | – | – | – | – | – | – | – | – | – | – | – | |
| C | – | – | – | – | – | – | – | – | – | – | – | – | |
| Recurrence of caries | A | 44 | 44 | 44 | 44 | 44 | 41 | 44 | 42 | 42 | 40 | 44 | 40 |
| B | – | – | – | – | – | – | – | – | – | – | – | – | |
| C | – | – | – | – | – | – | – | – | – | – | – | – | |
*PB-ER Prime&Bond Active etch-and-rinse, PB-SE Prime&Bond Active self-etch, CQ-ER, Clearfil Bond Quick etch-and-rinse, CQ-SE, Clearfil Bond Quick self-etch
**A = Alfa; B = Bravo; C = Charlie
Absolute risk (95% CI) and relative risk (95% CI) for outcome retention/fracture for different groups after 18 months of clinical evaluation
| Absolute risk (95% CI) | Relative risk (95% CI)* | |
|---|---|---|
| PB-ER | 4.5 (1.2–15.1) | |
| PB-SE | 9.1 (3.6–21.2) | − 1.0 (− 9.3–0.6) |
| CQ-ER | 0.0 (0.0–8.0) | 1.0 (0.0–0.0) |
| CQ-SE | 9.1 (3.6–21.2) | − 1.0 (-9.3–0.6) |
*Related to group: PB-ER Prime&Bond Active etch-and-rinse, PB-SE Prime&Bond Active self-etch, CQ-ER Clearfil Bond Quick etch-and-rinse, CQ-SE Clearfil Bond Quick self-etch
Number of evaluated restorations for each experimental group*classified according to the World Dental Federation (FDI) criteria [33]
| FDI criteria | ** | Baseline | 6 months | 18 months | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PB-ER | PB-SE | CQ-ER | CQ-SE | PB-ER | PB-SE | CQ-ER | CQ-SE | PB-ER | PB-SE | CQ-ER | CQ-SE | ||
| Marginal staining | A | 44 | 44 | 44 | 44 | 44 | 41 | 44 | 42 | 41 | 35 | 42 | 32 |
| B | – | – | – | – | – | – | – | – | 01 | 05 | 02 | 07 | |
| C | – | – | – | – | – | – | – | – | – | – | – | 01 | |
| D | – | – | – | – | – | – | – | – | – | – | - | – | |
| E | – | – | – | – | – | – | – | – | – | – | – | – | |
| Fractures and retention | A | 44 | 44 | 44 | 44 | 44 | 41 | 44 | 42 | 42 | 40 | 44 | 40 |
| B | – | – | – | – | – | – | – | – | – | – | – | – | |
| C | – | – | – | – | – | – | – | – | – | – | – | – | |
| D | – | – | – | – | – | 01 | – | – | – | – | – | – | |
| E | – | – | – | – | – | 02 | 02 | 02 | 01 | – | 02 | ||
| Marginal adaptation | A | 44 | 44 | 44 | 44 | 41 | 34 | 42 | 36 | 40 | 38 | 40 | 31 |
| B | – | – | – | – | 03 | 06 | 02 | 06 | 02 | 02 | 04 | 06 | |
| C | – | – | – | – | – | 01 | – | – | – | – | – | 03 | |
| D | – | – | – | – | – | – | – | – | – | – | – | – | |
| E | – | – | – | – | – | – | – | – | – | – | – | – | |
| Post-operative (hyper-) sensitivity | A | 44 | 44 | 44 | 44 | 44 | 42 | 44 | 42 | 42 | 40 | 44 | 39 |
| B | – | – | – | – | – | – | – | – | – | – | – | 01 | |
| C | – | – | – | – | – | – | – | – | – | – | – | – | |
| D | – | – | – | – | – | – | – | – | – | – | – | – | |
| E | – | – | – | – | – | – | – | – | – | – | – | – | |
| Recurrence of caries | A | 44 | 44 | 44 | 44 | 44 | 42 | 44 | 42 | 42 | 40 | 44 | 40 |
| B | – | – | – | – | – | – | – | – | – | – | – | – | |
| C | – | – | – | – | – | – | – | – | – | – | – | – | |
| D | – | – | – | – | – | – | – | – | – | – | – | – | |
| E | – | – | – | – | – | – | – | – | – | – | – | – | |
*PB-ER Prime&Bond Active etch-and-rinse, PB-SE Prime&Bond Active self-etch, CQ-ER Clearfil Bond Quick etch-and-rinse, CQ-SE Clearfil Bond Quick self-etch
**A = clinically very good; B = clinically good; C = clinically sufficient/satisfactory; D = clinically unsatisfactory; E = clinically poor